What is the current stock price of Pathfinder Cell Therapy, Inc. (PFND)?

As of the latest market data, Pathfinder Cell Therapy, Inc. (PFND) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Pathfinder Cell Therapy, Inc. (PFND) pay a dividend?

Based on current data, Pathfinder Cell Therapy, Inc. does not have a confirmed active dividend policy.

What is the market cap of Pathfinder Cell Therapy, Inc.?

The current market capitalization of Pathfinder Cell Therapy, Inc. (PFND) is approximately unavailable.

PFND

Pathfinder Cell Therapy, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2000-01-03

Beta

-24.33

Websitewww.pathfindercelltherapy.com↗